MAQUET Takes Over U.S. Distribution of Jostra Product Line
Dear Customer: Effective April 5, 2004 NOVOSCI will cease to be the distributor of Jostraproducts in the United States and MAQUET Inc. […]
World's Largest Resource for Cardiovascular Perfusion
Dear Customer: Effective April 5, 2004 NOVOSCI will cease to be the distributor of Jostraproducts in the United States and MAQUET Inc. […]
Both bovine and porcine valves have comparable results with regard to the mortality, postoperative functional status and valve durability. Significant variability between the valve manufacturers, study designs, study period and patient population in the above studies impose limitations to the comparison of both valves.
Quantitative NPi alone had excellent ability to predict a poor outcome from day 1 after VA-ECMO insertion, with no false positives. Combining NPi and 12-h PREDICT-VA ECMO score increased the sensitivity of outcome prediction, while maintaining 100% specificity.